PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,271 stories, page 234 of 638

Advanced search
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04620551: Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03971422: A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03845218: Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03148106: Hand Rehabilitation Study for Stroke Patients

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02621021: A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01792934: Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00894738: Measurement of Cardiometabolic Risk in Antipsychotic-Treated Children

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00001276: Diagnosing and Treating Low Blood Sugar Levels

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The retatrutide black market: Patient safety groups warn of growing risks from understudied drugs

Partnership for Safe MedicinesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Maharashtra FDA suspends licences of two online food delivery facilities

The HinduOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Who Is Heidi Overton, Trump’s Nominee to Lead the FDA?

Time MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

San Diego biotech’s at-home urine test aims to catch cancer early

San Diego Union-TribuneOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Stock Jumps 177% on Cancer Treatment Trial Success

조선일보Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump nominates Heidi Overton to lead US Food and Drug Administration

Al JazeeraOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

In a first, an mRNA cancer vaccine succeeds in late-stage clinical trial

Chemical & Engineering NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioMarin Pharmaceutical (BMRN)’s Alesta Deal Adds New Growth Potential in Rare Diseases

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Clene at Emerging Growth Conference: FDA path takes shape for ALS drug

Investing.comOriginal source
🇺🇸Researchnews.nm.orgTier 2 · Direct publisher

Volunteer inspired to serve patients at Northwestern Medicine Huntley Hospital after life-threatening neurological condition

Northwestern MedicineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moderna Stock Price Soars 177% on Melanoma Vaccine Success

Business InsiderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Pfizer (PFE) Stock Is Trading Up Today

StockStoryOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech launches public offering of common shares

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why Pfizer (PFE) Stock Is Trading Up Today

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech Announces Proposed Public Offering of Common Shares and Warrants

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fake drugs worth Rs5cr seized in Bidadi

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Edesa Biotech Announces Proposed Public Offering

WBOC TVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Disparate PV Systems Stall Drug Launches

Pharmaceutical CommerceOriginal source
🌍Researchopenclinica.comTier 2 · Direct publisher

From Longtime Customer to Formal Partner: S-cubed Biometrics Joins the OpenClinica CRO Partner Program

OpenClinicaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA SIDE EFFECTS UPDATE: Stelara and Alpha-Gal Allergy; Seizure Medication Linked to Severe Skin Reactions

MedShadow FoundationOriginal source
🇺🇸Researchorbimed.comTier 2 · Direct publisher

OrbiMed Named to TIME’s America’s Top Venture Capital Firms of 2026

OrbiMedOriginal source
🇿🇦Regulatorysahpra.org.zaTier 1 · Regulatory source

Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: Risk of Serious and Fatal Outcomes

SAHPRA South AfricaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump picks Dr. Heidi Overton, top White House aide, to lead the Food and Drug Administration

The Tribune-DemocratOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Regeneron's Pasatru scores FDA approval in ultra-rare bone lesions disorder

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

These Two Biotech Stocks Recorded Fresh Milestones Today – What’s Driving Today’s Gains?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vanda revives challenge over braille-free label on generic sleep disorder drug

Life Sciences IP ReviewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump Nominates Heidi Overton as FDA Chief; Pharma Sector on Watch

WhalesbookOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Merck, Moderna Report Positive Results for Their Melanoma Vaccine

Mexico Business NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Merck, Moderna Post Positive Phase 3 Melanoma Vaccine Data

Mexico Business NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Merck and Moderna Say mRNA Melanoma Vaccine Succeeds in Phase 3 Trial With Keytruda: how 39 outlets framed it

NewsCordOriginal source
🇺🇸universitynews.mit.eduTier 2 · Direct publisher

How the Toxoplasma parasite adapts to crowded conditions in host cells

MIT Biology NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Cancer treatment could face landmark moment with promising vaccine

The Washington PostOriginal source
🇺🇸CROmedpace.comTier 2 · Direct publisher

What Trends are Shaping Rheumatology Clinical Development in 2026?

MedpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

A ‘paradigm shift’: Moderna cancer vaccine results could herald new world of treatment

The Boston GlobeOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BioMarin spends up to $490m for Alesta’s bone disease candidate

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Experts scrutinize Huidagene’s disclosures after patient death

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump nominates aide Heidi Overton to lead US Food and Drug Administration

BBCOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Ars TechnicaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rockville biopharma firm slashes workforce by nearly two-thirds after drug trial fails

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump picks Dr. Heidi Overton, a top White House aide, to lead the Food and Drug Administration

San Bernardino SunOriginal source
🇯🇵Industrynippon-shinyaku.co.jpTier 1 · Company source

譲渡制限付株式報酬としての自己株式の処分の払込完了に関するお知らせ

Nippon Shinyaku NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trump picks Heidi Overton to lead FDA, pledges faster cures and lower drug prices

Business UpturnOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New 'landmark' drug shown to prevent recurrence of deadly melanoma

ABC News & Headlines – Australian Broadcasting CorporationOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fake, Expired Medicines Worth Rs 5 Crore Seized Repacking Unit In Bengaluru

NDTVOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Accepts Review of a Pancreatic Cancer Pill Already Reaching Patients Through an Expanded Access Program

inklOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ecopipam's D1 Receptor Approach Signals New Pediatric Neuroscience Pathway

PharmTech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Is Raising Concerns About Unapproved GLP-1 Weight-Loss Drugs

The Well NewsOriginal source